Applied BioCode Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	443.69	343.07	395.17	390.3	319.96	299.02
Revenue Growth (YoY)	14.85%	-13.18%	1.25%	21.98%	7.00%	185.61%
Cost of Revenue	185.83	139.07	126.43	156.13	130.6	105.49
Gross Profit	257.86	204	268.74	234.17	189.37	193.52
Selling, General & Admin	189.32	209.05	209.15	188.04	148.46	130.03
Research & Development	296.29	272.62	246.01	238.37	205.85	197.01
Operating Expenses	485.9	481.91	455.44	426.77	354.31	327.04
Operating Income	-228.04	-277.91	-186.7	-192.6	-164.94	-133.51
Interest Expense	-1.05	-1.43	-2.17	-2.78	-2.87	-4.31
Interest & Investment Income	27.24	27.63	23.96	8.51	3.11	3.73
Currency Exchange Gain (Loss)	0.81	-2.35	-0.31	1.22	-0	3.81
Other Non Operating Income (Expenses)	0.16	0.16	0.01	0.95	-0.46	-1.24
EBT Excluding Unusual Items	-200.87	-253.9	-165.21	-184.71	-165.17	-131.53
Gain (Loss) on Sale of Assets	-	-	-0.92	-	-0.01	-
Legal Settlements	-6.88	-6.88	-	-	-	-
Other Unusual Items	-	-	-	-	-	28.06
Pretax Income	-207.76	-260.78	-163.44	-184.71	-165.18	-103.47
Income Tax Expense	0.03	0.03	0.76	0.02	0.02	0.02
Net Income	-207.78	-260.81	-164.2	-184.73	-165.2	-103.5
Net Income to Common	-207.78	-260.81	-164.2	-184.73	-165.2	-103.5
Shares Outstanding (Basic)	103	91	82	82	82	78
Shares Outstanding (Diluted)	103	91	82	82	82	78
Shares Change (YoY)	20.48%	10.82%	0.01%	0.07%	5.33%	20.69%
EPS (Basic)	-2.02	-2.88	-2.01	-2.26	-2.02	-1.33
EPS (Diluted)	-2.02	-2.88	-2.01	-2.26	-2.02	-1.33
Free Cash Flow	-232.58	-215.12	-211.48	123.73	-167.29	-174.32
Free Cash Flow Per Share	-2.26	-2.37	-2.59	1.51	-2.05	-2.25
Gross Margin	58.12%	59.46%	68.01%	60.00%	59.18%	64.72%
Operating Margin	-51.40%	-81.01%	-47.25%	-49.35%	-51.55%	-44.65%
Profit Margin	-46.83%	-76.02%	-41.55%	-47.33%	-51.63%	-34.61%
Free Cash Flow Margin	-52.42%	-62.70%	-53.52%	31.70%	-52.29%	-58.30%
EBITDA	-183.99	-231.33	-139.2	-151.85	-128	-104.05
EBITDA Margin	-41.47%	-67.43%	-35.23%	-38.91%	-40.01%	-34.80%
D&A For EBITDA	44.05	46.58	47.5	40.75	36.94	29.46
EBIT	-228.04	-277.91	-186.7	-192.6	-164.94	-133.51
EBIT Margin	-51.40%	-81.01%	-47.25%	-49.35%	-51.55%	-44.65%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.